Raymond James Reiterates Outperform Rating on Compass Therapeutics (CMPX) following Q4 results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. HUMA
8. CME
9. cASY
10. TSLA

Go back to Raymond James Reiterates Outperform Rating on Compass Therapeutics (CMPX) following Q4 results
(NASDAQ: CMPX) Delayed: 2.03 +0.11 (5.73%)
Previous Close $1.92    52 Week High $ 
Open $1.91    52 Week Low $ 
Day High $2.04    P/E N/A 
Day Low $1.88    EPS $ 
Volume 1,766,444